Key facts
- Develo (Business/Productivity Software)’s last known valuation is $67.5M (Feb 2026).
- It has raised $13.5M; the latest was Early Stage VC ($10.0M) in Feb 2026.
- Notable investors include StartX (US), z21 Ventures, Fractal Software.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Develo (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for Develo (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Develo (Business/Productivity Software)
Developer of a pediatric software platform intended to improve the operations of independent pediatric practices. The company's platform manages day-to-day schedules, leverages check-in notifications and uses automated bi-directional outreach to capture critical information, enabling pediatricians to streamline scheduling, charting, billing and patient engagement.
- Sector
- Information Technology
- HQ
- Los Angeles, CA, United States
- Founded
- 2022
- Employees
- 5
- Website
- develo.com/
- Ownership
- Privately Held (backing)
Develo (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Develo (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Develo (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.